Sageworth Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,619
Closed -$250K 178
2025
Q4
$250K Sell
2,619
-168
-6% -$16.5K 0.01% 121
2025
Q3
$272K Buy
+2,787
New +$289K 0.01% 222
2020
Q3
Sell
-8
Closed 205
2020
Q2
$0 Buy
+8
New +$288 ﹤0.01% 228
2020
Q1
Sell
-1,085
Closed -$49K 182
2019
Q4
$49K Hold
1,085
0.01% 91
2019
Q3
$44K Hold
1,085
0.01% 96
2019
Q2
$47K Hold
1,085
0.01% 92
2019
Q1
$42K Sell
1,085
-3,160
-74% -$121K 0.01% 92
2018
Q4
$150K Hold
4,245
0.02% 46
2018
Q3
$163K Buy
4,245
+3,160
+291% +$110K 0.02% 47
2018
Q2
$35K Buy
+1,085
New +$32.7K 0.01% 56

Other funds holding BSX

Sageworth Trust's BSX Position: Q1 2026 in Review

Sageworth Trust sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,619 shares — an estimated $250K sold.

Sageworth Trust first reported a position in BSX in Q2 2018 and held it in 10 quarters. The position peaked at $272K in Q3 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Sageworth Trust reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Sageworth Trust sold 2,619 Boston Scientific shares in Q1 2026, an estimated $250K.
  • Sageworth Trust first reported a position in Boston Scientific in Q2 2018 and held it in 10 quarters.
  • Sageworth Trust's Boston Scientific position peaked at $272K in Q3 2025.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Sageworth Trust's 13F filing for Q1 2026, filed 29 Apr 2026.